Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Allison Berger"'
Autor:
Lunyin Yu Yu, Dirk Huebner, Yuhong Zhang, Jie Yu, Stephen Tirrell, Dan He McDougall, Helgi van de Velde, Allison Berger, Sakeena Syed, Christopher Tremblay, Nibedita Chattopadhyay
Publikováno v:
Blood. 128:1842-1842
The ubiquitin-proteasome system (UPS) represents the primary mechanism by which cells degrade proteins. Proteasome inhibition results in accumulation of proteasome substrates, leading to cell cycle disruption, endoplasmic reticulum (ER) stress, activ
Autor:
Thomas J. Waldschmidt, Michael R. Acevedo, Van S. Tompkins, Ramakrishna Sompallae, Kaylia Duncan, Alicia K. Olivier, Siegfried Janz, Herbert C. Morse, Guido Tricot, Lorraine T. Tygrett, Susan A. Walsh, Allison Berger, Laura L. Boles Ponto, John Sunderland, Fenghuang Zhan, Timothy R. Rosean
Publikováno v:
Blood Cancer Journal
(18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) and computed tomography (CT) are useful imaging modalities for evaluating tumor progression and treatment responses in genetically engineered mouse models of solid human cancers, but the
Autor:
Min Yang, David Tamang, Simon S. Jones, Steven N. Quayle, Khristofer Garcia, Jeffrey Ciavarri, Jie Yu, Allison Berger, Bret Bannerman
Publikováno v:
Blood. 122:4437-4437
Introduction The combination of HDAC inhibitors and proteasome inhibitors has demonstrated preclinical benefit in several settings, including multiple myeloma and lymphoma, and is being explored in clinical trials testing various HDAC inhibitors in c
Autor:
Paul E. Fleming, Mark Manfredi, Edmund Lee, Frank J. Bruzzese, Jane Liu, Erik Kupperman, Jonathan L. Blank, Paul Hales, Christopher Tsu, Michael Fitzgerald, Mark Rolfe, Li Yu, Allison Berger, Julie Zhang, Khristofer Garcia, Joseph B. Bolen, Jie Yu, Larry Dick, Bret Bannerman, Yueying Cao
Publikováno v:
Blood. 114:2709-2709
Abstract 2709 Poster Board II-685 Introduction: The ubiquitin-proteasome system processes the majority of cellular proteins and is the principal manner by which cells regulate protein homeostasis. The successful development of bortezomib for multiple